NCT05072626 High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia
| NCT ID | NCT05072626 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital of Fudan University |
| Condition | Biliary Atresia |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2021-10-11 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2021-10-11 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a prospective, single center and observational open clinical study.
Eligibility Criteria
Inclusion Criteria: The Kasai procedure for infants with biliary atresia under the age of 3 months. Exclusion Criteria: * Complicated with cirrhosis, hepatitis, or other hepatic disorders; * Complicated with other systemic serious diseases (such as congenital multiple malformations, chromosome abnormalities)
Contact & Investigator
Tian Qian, M.D. PhD
STUDY DIRECTOR
Children's Hospital of Fudan University
Frequently Asked Questions
Who can join the NCT05072626 clinical trial?
This trial is open to participants of all sexes, up to 3 Months, studying Biliary Atresia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05072626 currently recruiting?
Yes, NCT05072626 is actively recruiting participants. Contact the research team at drqiantian@fudan.edu.cn for enrollment information.
Where is the NCT05072626 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT05072626 clinical trial?
NCT05072626 is sponsored by Children's Hospital of Fudan University. The principal investigator is Tian Qian, M.D. PhD at Children's Hospital of Fudan University. The trial plans to enroll 300 participants.